Introduction

Polyhydramnios is an obstetric condition (i.e. occurring during pregnancy) characterised by an increase in amniotic fluid (the fluid that surrounds your baby) in pregnancy. Its incidence ranges from 0.2% to 1.6% overall. It can lead to poor pregnancy outcomes and fetal health if not managed. Many conditions are linked to polyhydramnios, and it may have many clinical presentations. In this article, we’ll explore the symptoms and causes of polyhydramnios, shedding light on its diagnostic criteria, associated risks, and management strategies.

Understanding polyhydramnios

Amniotic fluid is the water around your baby. Polyhydramnios is when it is present in excessive amounts in the womb. This occurs as a result of an imbalance between the production and resorption of amniotic fluid. The fluid levels are influenced by foetal urination, foetal swallowing, intramembranous absorption (the transfer of fluid between the baby and the placenta), and lung liquid formation. Amniotic fluid has various important functions; it provides a cushioning effect to protect the baby in the event of any trauma, has antibacterial properties to protect the baby from infections, acts as a reservoir of nutrients, and provides necessary space for the growth of the baby. 

Symptoms of polyhydramnios

Polyhydramnios can manifest with a range of symptoms, affecting both the mother and the foetus. Maternal symptoms may include heartburn and constipation, caused by the excessive distension or swelling of the uterus due to the increased amniotic fluid volume. Some women may experience shortness of breath or difficulty breathing due to pressure on the diaphragm, especially when lying down. Swelling, particularly in the lower extremities, may also be present.

Foetal symptoms of polyhydramnios often stem from the increased pressure exerted by the excess fluid. Rapid fetal growth may occur, leading to concerns about macrosomia (excessive fetal weight). Additionally, the foetus may have difficulty assuming the proper position for delivery due to the buoyancy provided by the excess fluid. In severe cases, polyhydramnios may be associated with an increased risk of certain complications, such as preterm labour, placental abruption, or umbilical cord prolapse.

Causes of polyhydramnios

The causes of polyhydramnios depend on my factors. There are some contributing foetal factors, such as: 

• Foetal anomalies (e.g., duodenal atresia, oesophageal atresia) which impair the baby’s ability to absorb the fluid
• Foetal genetic disorders (e.g., Down syndrome)
• Twin-to-twin transfusion syndrome (TTTS), a condition characterised by imbalanced blood flow between the foetuses, which can lead to polyhydramnios in one twin and oligohydramnios (low amniotic fluid) in the other and fetal anemia 

Maternal factors include: 

• Gestational Diabetes or Maternal Diabetes, which causes high levels of blood sugar in the baby and increased urination, which increases amniotic fluid production 
• Rh incompatibility, in which the mother's Rh-negative blood reacts to the foetus's Rh-positive blood, resulting in an immune reaction that can lead to polyhydramnios besity 
• Multiple pregnancies, which can lead to twin-to-twin transfusion syndrome 
• Viral Infections (Syphilis, Herpes, Rubella, Parvovirus 19, Cytomegalovirus) 
• Maternal hypercalcemia (high levels of calcium in the blood) 

In some instances, polyhydramnios may occur without an identifiable cause. This is referred to as Idiopathic Polyhydramnios.

Diagnosis 

The most common technique used to measure amniotic fluid is prenatal ultrasound. The amniotic fluid serves as a crucial diagnostic tool in monitoring the progression and health of pregnancy. Healthcare providers utilise methods such as the amniotic fluid index (AFI) or single deepest pocket (SDP) to assess its quantity. These measurements are components of the biophysical profile (a set of indicators used to measure the baby’s health), which also includes evaluations of foetal tone, foetal breathing, and non-stress tests. AFI and SDP involve ultrasound-based estimations of amniotic fluid volume. A diagnosis of polyhydramnios can be made if the AFI is ≥ 25 cm or the deepest pocket is ≥ 8cm. 

Polyhydramnios can be further categorised according to the AFI: 

• Mild polyhydramnios AFI: 25-30 cm, or vertical measurement of deepest pocket 8-11cm
• Moderate polyhydramnios AFI: 30.1 to 35 cm, or vertical measurement of deepest pocket 12-15cm
• Severe polyhydramnios AFI > 35 cm, or vertical measurement of deepest pocket ≥ 16cm

Management 

The management revolves around frequent monitoring of the patient, foetal well-being, underlying causes, and associated factors. Regular ultrasound scans are done to track changes in amniotic fluid volume. Underlying factors such as diabetes, viral infections or TTTS can be treated and may alleviate the polyhydramnios and its associated risks.

However, there are some treatment options also available that aim to reduce the amniotic fluid volume:

• Therapeutic Amniocentesis, which involves the removal of excess amniotic fluid via needle aspiration to relieve symptoms and reduce the risk of complications. This it is also known as amnioreduction. The intervention is usually concluded when ultrasound examination shows an AFI of 15 to 20 cm, or if intra-amniotic pressure drops to < 20 mmHg. However, it does have some risks, including premature labor, placental abruption, premature rupture of membranes, hyperproteinemia, and amniotic infection syndrome
• Pharmacological treatment, which involves the usa of medications to reduces fetal urine production

FAQs 

What is polyhydramnios?

Polyhydramnios, also known as hydramnios, is a condition characterised by an excessive accumulation of amniotic fluid in the womb during pregnancy. This increased fluid volume can pose risks to both the mother and the foetus and may require medical intervention.

What are the symptoms of polyhydramnios?

Polyhydramnios can manifest with a range of symptoms, including maternal abdominal discomfort, shortness of breath, and swelling. Foetal symptoms may include rapid fetal growth, difficulty in foetal positioning, and an increased risk of certain complications such as preterm labour or umbilical cord prolapse.

How is polyhydramnios diagnosed?

Polyhydramnios is typically diagnosed through prenatal ultrasound examinations, which assess amniotic fluid volume using methods such as the amniotic fluid index (AFI) or single deepest pocket (SDP). An AFI exceeding 24 cm or an SDP measuring more than 8 cm is considered indicative of polyhydramnios. Additionally, amniocentesis may be performed to assess for underlying genetic abnormalities or infections contributing to polyhydramnios.

What are the risks associated with polyhydramnios?

Polyhydramnios can increase the risk of complications during pregnancy and childbirth, including preterm labour, placental abruption, and umbilical cord prolapse. The excessive fluid volume may also lead to maternal discomfort and complications such as gestational hypertension or pre-eclampsia. Foetal risks may include foetal malposition, birth defects, or respiratory distress syndrome.

How is polyhydramnios managed and treated?

The management of polyhydramnios focuses on monitoring amniotic fluid levels and addressing underlying causes or associated complications. Treatment may involve managing maternal conditions such as diabetes, performing amnioreduction to remove excess fluid, or closely monitoring foetal well-being through regular ultrasound examinations. Interventions are tailored to the severity of the condition and its impact on maternal and foetal health.

Can polyhydramnios affect pregnancy outcomes?

Polyhydramnios may impact pregnancy outcomes depending on its severity and associated complications. Close monitoring and timely intervention are essential for minimising risks and optimising outcomes for both the mother and the foetus. Healthcare providers work collaboratively with pregnant individuals to manage polyhydramnios and ensure the best possible outcome for the pregnancy.

What should I do if I suspect I have polyhydramnios?

If you experience symptoms suggestive of polyhydramnios, such as abdominal discomfort or difficulty breathing, it is important to seek medical evaluation promptly. Your healthcare provider can perform diagnostic tests, such as ultrasound examinations, to assess amniotic fluid levels and determine appropriate management strategies. Early detection and intervention can help mitigate risks and ensure the health and well-being of both you and your baby throughout the pregnancy journey.

Can polyhydramnios be prevented?

In many cases, polyhydramnios cannot be prevented, especially when it is caused by underlying foetal or maternal factors. However, managing maternal conditions such as diabetes and receiving appropriate prenatal care may help reduce the risk of developing polyhydramnios or mitigate its severity. Regular prenatal check-ups and ultrasound examinations are essential for monitoring amniotic fluid levels and identifying any potential concerns early in pregnancy.

What are the long-term implications of polyhydramnios?

The long-term implications of polyhydramnios may vary depending on its underlying causes and associated complications. While some cases of polyhydramnios resolve after delivery without long-term consequences, others may require ongoing monitoring and management, especially if there are underlying foetal or maternal conditions. Your healthcare provider can provide personalised guidance based on your specific situation and ensure that you receive the appropriate care and support throughout your pregnancy and beyond.

Summary

Polyhydramnios presents unique challenges during pregnancy, requiring vigilant monitoring and management to optimise outcomes for both the mother and the foetus. By understanding the symptoms, causes, diagnosis, and management of polyhydramnios, healthcare providers can provide comprehensive care to pregnant individuals affected by this condition. Early detection and targeted interventions are essential for minimising risks and ensuring the health and well-being of both the mother and the unborn child throughout the pregnancy journey.